Comments
Loading...

Actuate Therapeutics Earnings Estimates

ACTUNASDAQ
Logo brought to you by Benzinga Data
$7.46
0.060.81%
At close: -
$7.44
-0.02-0.27%
After Hours: 7:32 AM EDT

Actuate Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ACTU | Benzinga

Actuate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 13
EPS
$-0.550
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Actuate Therapeutics using advanced sorting and filters.

Get Alert
ACTUActuate Therapeutics05/21/2025Get Alert
ACTUActuate Therapeutics04/01/2025Get Alert
ACTUActuate Therapeutics-$0.55$0.0011/13/2024Get Alert
ACTUActuate Therapeutics-$4.20$0.0009/24/2024Get Alert

Actuate Therapeutics (ACTU) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %

Actuate Therapeutics (ACTU) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?

A

Actuate Therapeutics (ACTU) is scheduled to report earnings on May 21, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Actuate Therapeutics (NASDAQ:ACTU)?

A

The Actual EPS was $-0.55, which missed the estimate of $0.00.

Q

What were Actuate Therapeutics’s (NASDAQ:ACTU) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch